Bioinformatics-based immunoassay of centromere protein L in pan-cancer

王芬,康金麟,李炫飞,冯茂辉,周福祥

DOI: https://doi.org/10.3760/cma.j.cn421213-20210907-01261

2022-01-01

Abstract:Objective:To investigate the expression of centromere protein L (CENPL) in pan-cancer and to investigate the relationship between CENPL expression and immune infiltration.Methods:The Human Protein Atlas and TIMER databases were used to explore the gene expression of CENPL in normal human tissues and 33 cancer types. Immune cell infiltration, ESTIMATE score, tumor mutational burden (TMB), microsatellite instability (MSI) and immune checkpoint genes correlation were calculated in 33 cancers using R language.Results:CENPL mRNA expression levels were higher in 16 tumors than in the corresponding paracancerous tissues (all P< 0.01). CENPL expression was correlated with immune cell infiltration in 31 tumors (all P< 0.05). In addition, the tumor with the highest correlation between CENPL expression levels and immune score was adrenocortical carcinoma ( R=-0.43, P<0.01); the tumor with the highest correlation with stromal score was testicular germ cell tumors ( R=-0.43, P<0.01); and the tumor with the highest correlation with ESTIMATE score was adrenocortical carcinoma ( R=-0.39, P<0.01). The CENPL expression was positively correlated with TMB in 18 tumors and negatively correlated with TMB in 2 cancers (all P<0.05). The CENPL expression was positively correlated with MSI in 5 cancers and negatively correlated with MSI in 3 cancers (all P<0.05). In renal clear cell carcinoma, the CENPL expression was significantly correlated with the expression of 40 immune checkpoints ( P<0.05). All differences were statistically significant. Conclusion:The CENPL expression is elevated in pan-cancer and is associated with immune infiltration in a variety of cancers.